Experimental Pathology Laboratory Shared Resource
Experimental Pathology Laboratory Shared Resource
批准号:
9772006
负责人:
Richard Brott Halberg
金额:
$0.33万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AddressAnimal ModelBiological AssayBiological MarkersCancer BiologyCancer Center Support GrantCancer EtiologyChargeComprehensive Cancer CenterConsultConsultationsCustomDataDevelopmentExperimental PathologyFundingHematoxylin and Eosin Staining MethodHistologyHistopathologyHourImmunofluorescence ImmunologicImmunohistochemistryInstitutesLaboratoriesMalignant NeoplasmsMethodsMissionMolecular AnalysisPathologistPathologyPreparationPrevention therapyPriceProceduresProcessProteinsProtocols documentationPublishingResearchResearch InfrastructureResearch PersonnelResearch SupportResource SharingSamplingSeminalServicesSlideSpecimenStainsStandardizationSurveysTissuesTrainingTranslational ResearchValidationWalkingWorkanticancer researchcostdata acquisitionexperiencefluorescence microscopehistotechnologyhuman modelimaging platforminterestliquid crystal polymermembermicroscopic imagingmolecular phenotypeneoplasticoperationprogramstherapeutic targetvirtual
中文摘要
项目摘要/摘要
实验病理学实验室(EPL)的使命是提供一系列全面的
组织病理学服务和专业知识,使UWCCC成员能够充分利用动物的力量
人类癌症模型,揭示癌症发生、发展和发展的机制
对治疗的反应性。EPL的工作人员在组织学、组织病理学和癌症方面拥有广泛的专业知识
生物学和Together在癌症研究方面拥有近100年的经验。EPL总共服务了99名
UWCCC成员在当前CCSG供资周期内,每年43至58个独立成员
在此时间间隔内使用的EPL服务。使用EPL的会员数量和服务量
自上次审查CCSG以来,提供的数据有所增加,2016年对成员的调查数据表明
使用量将继续增加。EPL优先考虑以下三个目标:目标1是提供基本的组织学
为UWCCC成员提供的服务。我们的成员利用各种各样的动物模型来处理重要的
关于癌症病因学、预防和治疗的问题。EPL通过提供以下信息支持这项研究
基本的组织学服务和专业知识。UWCCC调查人员收集的组织样本包括
传输到EPL,在那里根据
调查人员的要求和我们标准化的操作程序。EPL提供常见的染色
例如苏木精和伊红(H&E),几乎可以进行任何特殊染色。专家
病理咨询由Ruth Sullivan博士提供,Ruth Sullivan博士是委员会认证的兽医病理学家和EPL工作人员
成员。目的2是为了促进正常组织和肿瘤组织的分子分析。UWCCC成员
经常评估作为生物标志物或治疗性的特定蛋白质的表达、功能或定位
目标。应成员要求,EPL将开发和实施定制免疫组织化学
(IHC)或免疫荧光(IF)针对感兴趣的蛋白质。我们的成员认为这一点
服务是无价的,有70多个独特的IHC,或者协议已经开发、优化和验证
在当前CCSG供资周期内由EPL提供。目标3是为UWCCC提供组织病理学专业知识
成员和研究人员。EPL工作人员可即场咨询样品制备
以及操作或操作我们的尼康荧光显微镜进行图像采集。沙利文博士提供了
每月免费向UWCCC研究人员提供幻灯片评论和教程。此外,沙利文博士有空
做普通的病理学咨询。CCSG的支持使我们能够为UWCCC成员提供优先
以低于商业实验室的成本获得高质量的组织病理学服务,以及
向成员免费提供专家咨询支持。
英文摘要
PROJECT SUMMARY / ABSTRACT
The mission of the Experimental Pathology Laboratory (EPL) is to provide a comprehensive array of
histopathology services and expertise that enable UWCCC members to fully exploit the power of animal
models of human cancer to reveal mechanisms that contribute to cancer development, progression, and
responsiveness to therapies. EPL staff have extensive expertise in histology, histopathology, and cancer
biology and together possess nearly 100 years of experience in cancer research. EPL has served a total of 99
UWCCC members during the current CCSG funding cycle, and between 43 and 58 unique members per year
used EPL services during this interval. Both the number of members using EPL and the volume of services
provided have increased since the CCSG was last reviewed and data from a 2016 survey of members indicate
use will continue to increase. EPL prioritizes the following three aims: Aim 1 is to provide essential histology
services to UWCCC members. Our members utilize a wide variety of animal models to address important
questions pertaining to cancer etiology, prevention, and therapy. The EPL supports this research by providing
essential histology services and expertise. Tissue specimens collected by UWCCC investigators are
transported to the EPL where they are processed, embedded, sectioned, and stained according to the
requirements of the investigator and our Standardized Operating Procedures. EPL offers common staining
protocols, for example hematoxylin and eosin (H&E), and can perform virtually any special stain. Expert
pathology consultation is provided by Dr. Ruth Sullivan, a board certified veterinary pathologist and EPL staff
member. Aim 2 is to facilitate the molecular analyses of normal and neoplastic tissues. UWCCC members
frequently evaluate expression, function, or localization of specific proteins as biomarkers or therapeutic
targets. Upon request of a member, the EPL will develop and implement a custom immunohistochemistry
(IHC) or immunofluorescence (IF) protocol that is specific to a protein of interest. Our members view this
service as invaluable and over 70 unique IHC or IF protocols have been developed, optimized, and validated
by EPL during the current CCSG funding cycle. Aim 3 is to provide histopathology expertise to UWCCC
members and researchers. EPL staff members are available for walk-in consultation on sample preparation
and handling or on operation of our Nikon fluorescence microscope for image acquisition. Dr. Sullivan provides
monthly slide reviews and tutorials to UWCCC researchers free of charge. In addition, Dr. Sullivan is available
for general pathology consults. Support from the CCSG allows us to provide UWCCC members with priority
access to high quality histopathology services at costs below those of commercial laboratories as well as to
provide expert consultative support at no cost to members.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Features of the early adenoma and adjacent colon that drive progression: the role of mutation burden in normal tissue, senescent cells, and tumor clonal architecture
-
批准号:10707105
-
项目类别:
-
资助金额:$31.15万
-
财政年份:2022
-
负责人:Richard Brott Halberg
-
依托单位:
Features of the early adenoma and adjacent colon that drive progression: the role of mutation burden in normal tissue, senescent cells, and tumor clonal architecture
-
批准号:10519075
-
项目类别:
-
资助金额:$39.03万
-
财政年份:2022
-
负责人:Richard Brott Halberg
-
依托单位:
Molecular Differences Predicting Tumor Progression in Colorectal Cancer (PQ #14)
-
批准号:8538333
-
项目类别:
-
资助金额:$15.38万
-
财政年份:2012
-
负责人:Richard Brott Halberg
-
依托单位:
Molecular Differences Predicting Tumor Progression in Colorectal Cancer (PQ #14)
-
批准号:8384609
-
项目类别:
-
资助金额:$19.64万
-
财政年份:2012
-
负责人:Richard Brott Halberg
-
依托单位:
Polyclonal Intestinal Tumors: Formation, Progression, and Significance
-
批准号:7766296
-
项目类别:
-
资助金额:$33.18万
-
财政年份:2009
-
负责人:Richard Brott Halberg
-
依托单位:
Polyclonal Intestinal Tumors: Formation, Progression, and Significance
-
批准号:7652563
-
项目类别:
-
资助金额:$30.81万
-
财政年份:2009
-
负责人:Richard Brott Halberg
-
依托单位:
Polyclonal Intestinal Tumors: Formation, Progression, and Significance
-
批准号:8225175
-
项目类别:
-
资助金额:$29.89万
-
财政年份:2009
-
负责人:Richard Brott Halberg
-
依托单位:
Polyclonal Intestinal Tumors: Formation, Progression, and Significance
-
批准号:8446525
-
项目类别:
-
资助金额:$28.1万
-
财政年份:2009
-
负责人:Richard Brott Halberg
-
依托单位:
Polyclonal Intestinal Tumors: Formation, Progression, and Significance
-
批准号:8033178
-
项目类别:
-
资助金额:$29.89万
-
财政年份:2009
-
负责人:Richard Brott Halberg
-
依托单位:
MODIFIERS OF INTESTINAL NEOPLASIA IN MICE
-
批准号:2896499
-
项目类别:
-
资助金额:$4.17万
-
财政年份:1999
-
负责人:Richard Brott Halberg
-
依托单位:
MODIFIERS OF INTESTINAL NEOPLASIA IN MICE
-
批准号:2642965
-
项目类别:
-
资助金额:$3.28万
-
财政年份:1998
-
负责人:Richard Brott Halberg
-
依托单位:
Experimental Pathology Laboratory Shared Resource
-
批准号:9923031
-
项目类别:
-
资助金额:$4.99万
-
财政年份:--
-
负责人:Richard Brott Halberg
-
依托单位:
海外基金